Auswahl der wissenschaftlichen Literatur zum Thema „Direct cardiac reprogramming“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Direct cardiac reprogramming" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Direct cardiac reprogramming"
Qian, Li, und Deepak Srivastava. „Direct Cardiac Reprogramming“. Circulation Research 113, Nr. 7 (13.09.2013): 915–21. http://dx.doi.org/10.1161/circresaha.112.300625.
Der volle Inhalt der QuelleSadahiro, Taketaro, Shinya Yamanaka und Masaki Ieda. „Direct Cardiac Reprogramming“. Circulation Research 116, Nr. 8 (10.04.2015): 1378–91. http://dx.doi.org/10.1161/circresaha.116.305374.
Der volle Inhalt der QuelleBruneau, Benoit G. „Direct Reprogramming for Cardiac Regeneration“. Circulation Research 110, Nr. 11 (25.05.2012): 1392–94. http://dx.doi.org/10.1161/circresaha.112.270637.
Der volle Inhalt der QuelleChen, Olivia, und Li Qian. „Direct Cardiac Reprogramming: Advances in Cardiac Regeneration“. BioMed Research International 2015 (2015): 1–8. http://dx.doi.org/10.1155/2015/580406.
Der volle Inhalt der QuelleKim, Junyeop, Yujung Chang, Yerim Hwang, Sumin Kim, Yu-Kyoung Oh und Jongpil Kim. „Graphene Nanosheets Mediate Efficient Direct Reprogramming into Induced Cardiomyocytes“. Journal of Biomedical Nanotechnology 18, Nr. 9 (01.09.2022): 2171–82. http://dx.doi.org/10.1166/jbn.2022.3416.
Der volle Inhalt der QuelleZhang, Zhentao, Jesse Villalpando, Wenhui Zhang und Young-Jae Nam. „Chamber-Specific Protein Expression during Direct Cardiac Reprogramming“. Cells 10, Nr. 6 (16.06.2021): 1513. http://dx.doi.org/10.3390/cells10061513.
Der volle Inhalt der QuelleSadahiro, Taketaro. „Direct Cardiac Reprogramming ― Converting Cardiac Fibroblasts to Cardiomyocytes ―“. Circulation Reports 1, Nr. 12 (10.12.2019): 564–67. http://dx.doi.org/10.1253/circrep.cr-19-0104.
Der volle Inhalt der QuelleIeda, Masaki. „Direct cardiac reprogramming by defined factors“. Inflammation and Regeneration 33, Nr. 4 (2013): 190–96. http://dx.doi.org/10.2492/inflammregen.33.190.
Der volle Inhalt der QuelleEngel, James L., und Reza Ardehali. „Direct Cardiac Reprogramming: Progress and Promise“. Stem Cells International 2018 (2018): 1–10. http://dx.doi.org/10.1155/2018/1435746.
Der volle Inhalt der QuelleKurotsu, Shota, Takeshi Suzuki und Masaki Ieda. „Mechanical stress regulates cardiac direct reprogramming“. Proceedings for Annual Meeting of The Japanese Pharmacological Society WCP2018 (2018): OR15–1. http://dx.doi.org/10.1254/jpssuppl.wcp2018.0_or15-1.
Der volle Inhalt der QuelleDissertationen zum Thema "Direct cardiac reprogramming"
Bachamanda, Somesh Dipthi [Verfasser]. „Induced cardiomyocyte precursor cells obtained by direct reprogramming of cardiac fibroblasts / Dipthi Bachamanda Somesh“. Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2020. http://d-nb.info/1223925676/34.
Der volle Inhalt der QuelleElkhoury, Kamil. „Nanofunctionalization and biofabrication of natural hydrogels for tissue engineering applications“. Electronic Thesis or Diss., Université de Lorraine, 2021. http://www.theses.fr/2021LORR0020.
Der volle Inhalt der QuelleThe main objective of this thesis is to develop a new natural material based on methacrylated gelatin (GelMA) nanofunctionalized by the incorporation of nanoliposomes or soft hybrid exosome-liposome nanoparticles. The physicochemical and biological properties of these hydrogel matrices were characterized in order to evaluate their potential use for tissue engineering applications. GelMA is prepared by the chemical modification of gelatin when methacrylate groups are attached to side groups containing amine functions. In a first part of this work, the influence of the gelatin source (pork or fish) and the degree of methacrylation on the physicochemical and biological properties of hydrogels was studied. In a second part of this work, the GelMA matrix was nanofunctionalized by the incorporation of nanoliposomes, which are soft and natural nanoparticles with remarkable self-assembly properties. These well-established drug delivery systems are formed of lipid bilayers and can transport and release hydrophobic, hydrophilic, and amphiphilic molecules. In this study, naringin, an active molecule that can guide the differentiation process of stem cells to the osteoblastic lineage, was encapsulated in nanoliposomes before their incorporation into the GelMA polymeric matrix in order to develop a system of interest for bone regeneration applications. This nanocomposite material was physicochemically and biologically characterized and the release profile of naringin was investigated. In a third and final part of this work, the GelMA matrix was nanofunctionalized by the incorporation of exosome-liposome soft hybrid nanoparticles. Exosomes, natural nanovesicles secreted by cells, are of increasing interest for targeted drug delivery applications due to the presence of cell specific receptors on their surface. The hybrid GelMA hydrogels were physicochemically and biologically characterized for applications in cardiac reprogramming and was successfully bioprinted and microfabricated. Biofabricated GelMA hydrogels nanofunctionalized with nanoliposomes or hybrid exosome-liposome nanoparticles are promising platforms for the controlled release of bioactive molecules and for tissue engineering applications
Buchteile zum Thema "Direct cardiac reprogramming"
Haginiwa, Sho, und Masaki Ieda. „Direct Cardiac Reprogramming“. In Cardiac and Vascular Biology, 123–43. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56106-6_6.
Der volle Inhalt der QuelleLiu, Dingqian, Khawaja Husnain Haider und Changfa Guo. „Bioengineering Technique Progress of Direct Cardiac Reprogramming“. In Handbook of Stem Cell Therapy, 1333–65. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-2655-6_27.
Der volle Inhalt der QuelleJayawardena, Tilanthi, Maria Mirotsou und Victor J. Dzau. „Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes Using MicroRNAs“. In Methods in Molecular Biology, 263–72. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0512-6_18.
Der volle Inhalt der QuellePaoletti, Camilla, Carla Divieto und Valeria Chiono. „Direct Reprogramming of Adult Human Cardiac Fibroblasts into Induced Cardiomyocytes Using miRcombo“. In Methods in Molecular Biology, 31–40. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2707-5_3.
Der volle Inhalt der QuelleMa, Hong, Li Wang, Jiandong Liu und Li Qian. „Direct Cardiac Reprogramming as a Novel Therapeutic Strategy for Treatment of Myocardial Infarction“. In Methods in Molecular Biology, 69–88. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-6588-5_5.
Der volle Inhalt der QuellePaoletti, Camilla, Carla Divieto und Valeria Chiono. „Correction to: Direct Reprogramming of Adult Human Cardiac Fibroblasts into Induced Cardiomyocytes Using miRcombo“. In Methods in Molecular Biology, C1. New York, NY: Springer US, 2023. http://dx.doi.org/10.1007/978-1-0716-2707-5_27.
Der volle Inhalt der QuelleJain, Pooja, Nazia Hassan, Uzma Farooq und Zeenat Iqbal. „Nanotechnology-Based Direct Cardiac Reprogramming for Cardiac Regeneration“. In Nanomedicinal Approaches Towards Cardiovascular Disease, 106–24. BENTHAM SCIENCE PUBLISHERS, 2021. http://dx.doi.org/10.2174/9789814998215121010015.
Der volle Inhalt der QuelleHaridhasapavalan, Krishna Kumar, Atreyee Borthakur und Rajkumar P. Thummer. „Direct Cardiac Reprogramming: Current Status and Future Prospects“. In Advances in Experimental Medicine and Biology. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/5584_2022_760.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Direct cardiac reprogramming"
Klose, K., M. Gossen und C. Stamm. „Direct Genetic and/or Pharmacologic Reprogramming for Creation of Cardiomyocytes: Is It Real?“ In 48th Annual Meeting German Society for Thoracic, Cardiac, and Vascular Surgery. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1678823.
Der volle Inhalt der Quelle